Finance

Lists
Why is 300529 up 2,28%?
Dive Deeper
300529:SHE
Jafron Biomedical Co Ltd
15,26 CN¥
+2,28%
(+0,34) 1D
19 қаз., 15:04:22 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300529...
Open
14,89 CN¥
High
15,33 CN¥
Low
14,86 CN¥
Mkt. cap
11,92 млрд
Avg. vol.
4,09 млн
Volume
6,15 млн
Dividend
3,41%
Quarterly dividend
0,13 CN¥
Ex-dividend date
2026 ж. 01 мау.
P/E ratio
22,78
52-wk high
21,96 CN¥
52-wk low
14,73 CN¥
EPS
0,67 CN¥
Shares outstanding
798,61 млн
No. of employees
2 мың
Open
14,89 CN¥
High
15,33 CN¥
Low
14,86 CN¥
Mkt. cap
11,92 млрд
Avg. vol.
4,09 млн
Volume
6,15 млн
Dividend
3,41%
Quarterly dividend
0,13 CN¥
Ex-dividend date
2026 ж. 01 мау.
P/E ratio
22,78
52-wk high
21,96 CN¥
52-wk low
14,73 CN¥
EPS
0,67 CN¥
Shares outstanding
798,61 млн
No. of employees
2 мың
News stories
From web sources and news partners
About Jafron Biomedical Co Ltd
CEO-
Employees2,2 мың
Founded1989 ж. 19 жел.
Headquarters-
SectorMedical device
Websitejafron.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
421,61 млн
455,80 млн
560,62 млн
471,85 млн
Cost of goods sold
82,44 млн
122,83 млн
127,54 млн
110,75 млн
Cost of revenue
82,44 млн
122,83 млн
127,54 млн
110,75 млн
Research and development expenses
49,57 млн
51,42 млн
45,69 млн
57,40 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
172,41 млн
135,77 млн
115,42 млн
117,22 млн
Operating expense
226,42 млн
197,92 млн
166,90 млн
187,46 млн
Total operating expenses
308,86 млн
320,75 млн
294,44 млн
298,21 млн
Operating income
112,74 млн
135,05 млн
266,18 млн
173,64 млн
Other non operating income
-2,81 млн
3,02 млн
-1,18 млн
325,24 м.
EBT including unusual items
90,15 млн
108,07 млн
260,01 млн
187,12 млн
EBT excluding unusual items
100,80 млн
171,31 млн
258,91 млн
167,29 млн
Income tax expense
26,96 млн
28,26 млн
39,37 млн
24,78 млн
Effective tax rate
29,91%
26,15%
15,14%
13,24%
Other operating expenses
7,07 млн
8,52 млн
4,18 млн
13,61 млн
Net income
63,51 млн
79,59 млн
220,51 млн
161,46 млн
Net profit margin
15,06%
17,46%
39,33%
34,22%
Earnings per share
-
-
-
-
Interest and investment income
3,94 млн
48,69 млн
6,26 млн
9,06 млн
Interest expense
-13,41 млн
-13,28 млн
-12,35 млн
-12,43 млн
Net interest expenses
-9,47 млн
35,41 млн
-6,09 млн
-3,37 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
143,16 млн
164,34 млн
295,47 млн
203,48 млн
Gain or loss from assets sale
-1,41 млн
79,85 мың
-
-113,20 м.
AI content may include mistakes. Learn more
Google қолданбалары